This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

RISPERDAL Oral Solution - Stability in Plastic Syringes

Last Updated: 05/08/2024

PRODUCT LABELING

Please refer to the following sections of the enclosed Full Prescribing Information that are relevant to your inquiry: DOSAGE AND ADMINISTRATION, DOSAGE FORMS AND STRENGTHS, DESCRIPTION, and HOW SUPPLIED/STORAGE AND HANDLING.1

STABILITY IN PLASTIC SYRINGES

Stability data on repackaging and dispensing risperidone oral solution in plastic syringes has not been conducted.  However, results of physical/chemical studies reveal no incompatibilities when the solution is administered using the oral dosing syringe provided as described in the RISPERDAL Prescribing Information.

References

1 RISPERDAL (risperidone) [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc; https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/RISPERDAL-pi.pdf.